Risky Business: Cardiac Prevention, Stratification, and Novel Non-Invasive Diagnostics (2025)

Only available as part of a package

Learning Objectives:

  • Improve discussions on lifestyle changes and comorbid management for primary prevention of atherosclerotic cardiovascular disease (ASCVD)
  • Understand risk stratification testing for prediction of ASCVD and secondary prevention treatments.
  • Increase awareness of novel testing for ASCVC utilizing non-invasive imaging.

Marcel Letourneau, DO (he/him/his)

Interventional Cardiology

Corewell Health West

Interventional Cardiology, Corwell Health West Heart and Vascular Center. 

VTE Director Holland Hospital.

The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose. 

Key:

Complete
Failed
Available
Locked
Pre-Test
5 Questions  |  1 attempt  |  0/5 points to pass
5 Questions  |  1 attempt  |  0/5 points to pass
You must register to access.
Webcast
04/24/2025 at 10:30 AM (EDT)  |  Recorded On: 04/24/2025  |  30 minutes
04/24/2025 at 10:30 AM (EDT)  |  Recorded On: 04/24/2025  |  30 minutes
You must register to access.
Post-Test
5 Questions  |  Unlimited attempts  |  4/5 points to pass
5 Questions  |  Unlimited attempts  |  4/5 points to pass
You must register to access.
Evaluation
17 Questions
17 Questions
You must register to access.